BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 1, 2003
View Archived Issues
Praecis Gets First Approval: Plenaxis In Prostate Cancer
Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today)
Read More
Genentech's Avastin Misses Primary Endpoint In Phase II
Read More
Largest Stroke Trials Worldwide Compare Oral Anti-Ischemic Drugs With Current Warfarin Prevention
Read More
Medicare Bill To White House; Most Applaud New Regulations
Read More
Holiday Notice
Read More
Chronogen Series B Raises C$17M For Longevity Work
Read More
Other News To Note
Read More